Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > So when LABS CEO stated they have over 20 'strong' clinical

<< Previous

Bullboard Posts

Next >>

Comment by mdjbrownon Mar 07, 2024 5:11pm

86 Views

Post# 35921466

RE:RE:RE:So when LABS CEO stated they have over 20 'strong' clinical

It certainly doesnt happen over night, but the LiBBY Trial has promise with both the FDA and DEA on board. Not to mention the $16 million award from NIH to Keck

Treatment of Alzheimer’s Agitation Disorder Phase 2

Recent Milestone: "FDA approval of Investigational New Drug (IND) Clinical trial material (CTM) delivered and enrollment commencing in Q3 2023 Second CTM delivery approval from US DEA has been received."

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec